Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Seamlessly bridge your LNP discovery journey from RUO to bulk GLP-tox and GMP excipient-grade material.
Explore CGMP Lipid Services1A7B13 is a lung-targeted cationic lipid that has been used in the generation of lipid nanoparticles (LNPs) for the delivery of mRNA, single-guide RNA (sgRNA), and siRNA in vivo.1 LNPs containing 1A7B13 accumulate in the lung to a greater extent than those containing DOTAP (Item Nos. 15110 | 38905). LNPs containing 1A7B13 and encapsulating IL-10 mRNA reduce acute weight loss and interstitial congestion and inflammation and increase bronchoalveolar lavage fluid (BALF) levels of IL-10 in a mouse model of LPS-induced acute lung injury.
WARNING This product is not for human or veterinary use.
1. 'Tripod-